News

Joyce Fitzharris

SK pharmteco Announces Appointment of a New President for SK biotek Ireland

Press Release | For Immediate Release  SK pharmteco Inc (SKPT) is pleased to announce that Joyce Fitzharris, currently serving as General Manager, SK biotek Ireland has been promoted to the office of President, SK biotek Ireland. Growth in our business base and projected expansions continue to support SK biotek Ireland’s position as a key contributor …

SK pharmteco Announces Appointment of a New President for SK biotek Ireland Read More »

SMB

Continuous Process Implementation: A CMO Perspective

Read a CMO’s perspective on Continuous Process Implementation  Recently published in TKS | publisher’s ChemicalToday click the link to read the article by Olivier Dapremont, Executive Director of AMPAC Fine Chemicals an SK pharmteco Company,  and view the full supplement https://lnkd.in/efHDCqe

Celebrating AMPAC Day in Petersburg, Virginia

PETERSBURG, Va., June 17, 2021  The City of Petersburg, home to AMPAC Fine Chemicals Virginia, declared June 17, 2021 as “AMPAC Day”. An event was held in appreciation of AFC’s employees and to further cultivate a positive relationship with the local community.

AMPAC Fine Chemicals Creating Jobs with Expansion in Virginia

AMPAC Fine Chemicals Creating Jobs with Expansion in Virginia Investment will triple local employment and strengthen regional pharma industry Furthers SK Group’s plans to invest in and grow U.S. businesses PETERSBURG, Va., May 4, 2021 AMPAC Fine Chemicals (AFC), an SK pharmteco company, is creating more than 150 new jobs and investing more than $25 …

AMPAC Fine Chemicals Creating Jobs with Expansion in Virginia Read More »

SK pharmteco Expands into Cell and Gene Therapy With the Acquisition of French CDMO Yposkesi

SK pharmteco Expands into Cell and Gene Therapy With the Acquisition of French CDMO Yposkesi Rancho Cordova, California, April 28, 2021 SK pharmteco, a global contract development and manufacturing organization (CDMO) specializing in the manufacture of active pharmaceutical ingredients (APIs) and advanced intermediates, recently announced the acquisition of the major interest in Yposkesi. Yposkesi is …

SK pharmteco Expands into Cell and Gene Therapy With the Acquisition of French CDMO Yposkesi Read More »

Scroll to Top